What are the latest advances in Dermatillomania?

Dermatillomania, also known as Excoriation Disorder, is currently seeing a research shift toward neurobiological interventions, moving beyond traditional behavioral therapies to explore pharmacological and brain-stimulation approaches. While there is no single "cure," ongoing clinical investigations are focused on modulating glutamate pathways and neural circuits associated with impulse control to better manage the compulsive skin picking cycle.

What are the most promising research directions for Dermatillomania?

Recent research into Dermatillomania has increasingly focused on the neurobiology of the glutamatergic system. Studies are examining whether modulating this neurotransmitter can reduce the urge to pick. Additionally, researchers are investigating the role of executive function and sensory processing in individuals with Dermatillomania, seeking to understand why physical sensations or stressors trigger the skin-picking behavior.

Are there new pharmacological or medical breakthroughs?

While no FDA-approved medication exists specifically for Dermatillomania, clinical interest is high in the following areas:

• N-Acetylcysteine (NAC): A dietary supplement being studied for its role in regulating glutamate levels to potentially dampen the compulsive urge.


• Neuromodulation: Investigations into transcranial magnetic stimulation (TMS) as a tool to reset neural pathways involved in impulse regulation.


• Combination Therapies: Research is exploring the synergy between Habit Reversal Training (HRT) and targeted SSRI usage to improve outcomes for those with comorbid anxiety.

How are diagnostic tools evolving for Dermatillomania?

Researchers are working to develop more objective diagnostic criteria for Dermatillomania to move beyond self-reporting. Current efforts include the use of standardized scales like the Skin Picking Scale-Revised (SPS-R) to better quantify symptom severity, alongside neuroimaging studies that attempt to map the brain regions—such as the anterior cingulate cortex—that are overactive during picking episodes.

Where is leading research on Dermatillomania being conducted?

Global efforts are led by institutions such as the International OCD Foundation (IOCDF), which maintains specialized resources for body-focused repetitive behaviors (BFRBs). Academic centers in the U.S. and Europe are currently conducting trials to compare various behavioral interventions, and 260 members of the DiseaseMaps.org community are actively sharing their experiences to help researchers identify patterns in symptom triggers.

Next steps

• Visit ClinicalTrials.gov and search for "Excoriation Disorder" or "Dermatillomania" to view active, recruiting studies.


• Consult with a psychiatrist specializing in BFRBs to discuss off-label medication options based on the latest clinical guidelines.


• Join the DiseaseMaps.org community to connect with peers and stay updated on the latest patient-reported outcomes.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with a qualified healthcare professional regarding any clinical diagnosis or treatment changes.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Excoriation Disorder


• International OCD Foundation (IOCDF): BFRB Research Updates


• PubMed/NCBI: Current clinical perspectives on N-acetylcysteine in impulse control disorders